Your account is not claimed yet. You can sign up with ORCID to claim your account.

Rob N de Jong (Bart de Jong)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2022
Publications (10 Years): 4

Top Venues

Nature biotechnology

Nature protocols

Proceedings of the National Academy of Sciences of the United States of America

Science (New York, N.Y.)

Genmab (Netherlands)

Universiteit Utrecht (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genmab (Netherlands) Jul 15o 2007

Netherlands

Director :: Antibody Research & Technology

Education History

Universiteit Utrecht

Netherlands

PHD :: Physiological Chemistry

Publications

Simone C Oostindie, Derek A Rinaldi, Gijs G Zom, Michael J Wester, Desiree Paulet, Kusai Al-Tamimi, Els van der Meijden, Jennifer R Scheick, Tessa Wilpshaar, Bart de Jong, Marloes Hoff-van den Broek, Rachel M Grattan, Janita J Oosterhoff, Julie Vignau, Sandra Verploegen, Peter Boross, Frank J Beurskens, Diane S Lidke, Janine Schuurman, Rob N de Jong
Logic-gated antibody pairs that selectively act on cells co-expressing two antigens. Nature biotechnology 40 (10) (2022)
Ana Rita Cruz, Maurits A den Boer, Jürgen Strasser, Seline A Zwarthoff, Frank J Beurskens, Carla J C de Haas, Piet C Aerts, Guanbo Wang, Rob N de Jong, Fabio Bagnoli, Jos A G van Strijp, Kok P M van Kessel, Janine Schuurman, Johannes Preiner, Albert J R Heck, Suzan H M Rooijakkers
Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation. Proceedings of the National Academy of Sciences of the United States of America 118 (7) (2021)
Marije B Overdijk, Kristin Strumane, Frank J Beurskens, Antonio Ortiz Buijsse, Claudine Vermot-Desroches, Boris S Vuillermoz, Thessa Kroes, Rob N de Jong, Naomi Hoevenaars, Richard G Hibbert, Andreas Lingnau, Ulf Forssmann, Janine Schuurman, Paul W H I Parren, Esther C W Breij
Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism. Molecular cancer therapeutics 19 (10) (2020)
Deniz Ugurlar, Stuart C Howes, Bart-Jan de Kreuk, Roman I Koning, Rob N de Jong, Frank J Beurskens, Janine Schuurman, Abraham J Koster, Thomas H Sharp, Paul W H I Parren, Piet Gros
Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement. Science (New York, N.Y.) 359 (6377) (2018)
Aran F Labrijn, Joyce I Meesters, Patrick Priem, Rob N de Jong, Ewald T J van den Bremer, Muriel D van Kampen, Arnout F Gerritsen, Janine Schuurman, Paul W H I Parren
Controlled Fab-arm exchange for the generation of stable bispecific IgG1. Nature protocols 9 (10) (2014)

Rob N de Jong.css-eqlu8i{font-size:small;padding-left:4px;} (Bart de Jong)

Publication Activity (10 Years)

Top Topics

Top Venues

Rob N de Jong (Bart de Jong)